CJC-1295 without DAC and Ipamorelin are both synthetic peptides designed to stimulate the release of growth hormone (GH) from the pituitary gland. While they share the common goal of enhancing GH levels, their mechanisms of action and specific applications differ. This article provides a detailed comparison of these two peptides based on their class, mechanism, benefits, administration protocols, and potential risks.
| CJC-1295 without DAC (Modified GRF 1-29 / Mod-GRF) | Ipamorelin | |
|---|---|---|
| Drug class | CJC-1295 without DAC is a synthetic analog of Growth Hormone-Releasing Factor (GRF). | Ipamorelin is a synthetic growth hormone-releasing peptide (GHRP). |
| Mechanism | CJC-1295 without DAC acts as a potent stimulator of GH release by binding to the GRF receptor. | Ipamorelin stimulates GH release by binding to the growth hormone secretagogue receptor (GHS-R), requiring endogenous hypothalamic GHRH for maximal GH stimulation. |
| Primary use | Enhances GH and IGF-1 release for muscle growth, fat loss, and overall body composition. | Stimulates HGH release for lean muscle growth, fat loss, and cell synthesis. |
| Administration | Typical dosing: 100-300 mcg, subcutaneously every 1-3 days. | Typical dosing: 50-200 mcg, subcutaneously, 1-3 times daily. |
| Evidence strength | Limited research-documented benefits; primarily general-knowledge benefits. | Some research-documented benefits, with additional general-knowledge benefits. |
| Risks/contraindications | May exacerbate conditions affected by GH excess, limited long-term safety data. | May cause side effects related to GH excess, not recommended for individuals with a history of cancer or pituitary disorders. |
Mechanism of Action
CJC-1295 without DAC is a synthetic analog of Growth Hormone-Releasing Factor (GRF), a 29-amino acid fragment of the natural 44-amino acid peptide [1]. It acts as a potent stimulator of growth hormone (GH) release from the anterior pituitary gland by binding to the GRF receptor, thereby increasing circulating GH levels. In contrast, Ipamorelin is a synthetic growth hormone-releasing peptide (GHRP) that acts as a potent agonist of the growth hormone secretagogue receptor (GHS-R). It stimulates the release of GH from the pituitary gland by binding to this receptor, which requires endogenous hypothalamic GHRH for maximal GH stimulation [2].
Benefits
Both CJC-1295 without DAC and Ipamorelin have been associated with benefits related to muscle growth, fat loss, and overall body composition. CJC-1295 without DAC enhances the release of GH and IGF-1, which are crucial for muscle growth, fat loss, and overall body composition [2]. It may also improve skin quality and promote wound healing due to its anabolic effects [39]. Ipamorelin stimulates the pituitary to release HGH, supporting lean muscle growth and fat loss [2]. Consistent usage can increase cell synthesis and elevate insulin secretion from pancreatic tissue [2]. It also increases ghrelin in the stomach, which helps release HGH and control hunger [2].
Administration
The typical dosing protocol for CJC-1295 without DAC is within the range of 100-300 mcg, administered subcutaneously every 1-3 days. Ipamorelin is typically administered at a dose of 50-200 mcg, subcutaneously, 1-3 times daily [2].
Risks and Contraindications
As potentiators of GH release, both CJC-1295 without DAC and Ipamorelin may exacerbate conditions affected by GH excess, such as acromegaly or certain tumors [3]. Long-term safety data for CJC-1295 without DAC is limited, and it should be used with caution in individuals with a history of cancer or other proliferative disorders. Ipamorelin may cause side effects related to GH excess, such as fluid retention, joint pain, and potential worsening of sleep apnea. It is not recommended for individuals with a history of cancer or pituitary disorders due to the potential for exacerbating GH-related conditions [2].
References
- Aging and genome maintenance_ lessons from the growth hormone receptor knockout mouse
- Anabolics
- Anabolics 10th Edition
- Basic and Clinical Aspects of Growth Hormone
- Biochemistry
- Boundless Upgrade Your Brain, Optimize Your Body and Defy — Ben Greenfield
- Endocrinology_ Adult and Pediatric
- Energy Metabolism and Obesity_ Research and Clinical Applications
- GHRH, GH, and IGF-1_ Basic and Clinical Advances
- Grow young with HGH _ the amazing medically proven plan to
- Growth Hormone Secretagogues
- Growth Hormone Secretagogues in Clinical Practice
- Growth hormone releasing peptides
- Handbook of Biologically Active Peptides
- Life Force
- Live Longer, Live Well_ The 6 Lifestyle Pillars for a Long and Healthy Life
- Living a Fully Optimized Life
- Mass Spectrometry in Medicinal Chemistry
- Peptides and Non Peptides of Oncologic and Endocrine Interest
- Performance-Enhancing Substances in Sport and Exercise